Cargando…
Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509023/ https://www.ncbi.nlm.nih.gov/pubmed/32767277 http://dx.doi.org/10.1007/s13300-020-00899-7 |
_version_ | 1783585516182044672 |
---|---|
author | Iwahori, Toshiyuki |
author_facet | Iwahori, Toshiyuki |
author_sort | Iwahori, Toshiyuki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7509023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-75090232020-10-05 Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment Iwahori, Toshiyuki Diabetes Ther Letter Springer Healthcare 2020-08-07 2020-10 /pmc/articles/PMC7509023/ /pubmed/32767277 http://dx.doi.org/10.1007/s13300-020-00899-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Letter Iwahori, Toshiyuki Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title | Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title_full | Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title_fullStr | Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title_full_unstemmed | Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title_short | Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment |
title_sort | letter to the editor regarding: patient preferences for glp-1 receptor agonist treatment of type 2 diabetes mellitus in japan: a discrete choice experiment |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509023/ https://www.ncbi.nlm.nih.gov/pubmed/32767277 http://dx.doi.org/10.1007/s13300-020-00899-7 |
work_keys_str_mv | AT iwahoritoshiyuki lettertotheeditorregardingpatientpreferencesforglp1receptoragonisttreatmentoftype2diabetesmellitusinjapanadiscretechoiceexperiment |